Stanford University
Showing 2,071-2,080 of 7,810 Results
-
Matthew Fitzgerald, PhD
Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly InterestsMy research encompasses several translational projects. One focus is to modify the routine audiologic test battery such that it places equal weight on hearing acuity and hearing function. This work includes measures of speech in noise, or electrophysiologic responses such as the FFR. I also explore tools to better assess and maximize performance in users of hearing aids and cochlear implants. Finally, I am also investigating the benefits of telemedicine, and new treatments for tinnitus.
-
Peter Fitzgerald, MD, PhD
Professor (Research) of Medicine (Cardiovascular), Emeritus
BioDr. Peter Fitzgerald is the Director of the Center for Cardiovascular Technology and the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University School of Medicine. He is an interventional cardiologist and holds a PhD in engineering. He is a professor in both the Department of Medicine and the Department of Engineering (by courtesy) at Stanford.
Dr. Fitzgerald has led or participated in more than 175 clinical trials, has published more than 550 manuscripts and book chapters, and lectures worldwide. Over the past two decades, he has trained more than 150 postdoctoral researchers in engineering and medicine. Most recently, Dr. Fitzgerald completed two years of study toward a master’s degree focused on machine learning and agentic principles supporting AI.
Dr. Fitzgerald has been a principal founder of 24 medical startups in the San Francisco Bay Area and has transitioned 17 of them to large medical device companies. He serves on several boards of directors and advises dozens of medical device startups, as well as multinational healthcare companies, on the design and development of new diagnostic and therapeutic devices in the cardiovascular arena. In 2001, Dr. Fitzgerald was part of the founding team of LVP Capital, a venture firm focused on medical device and biotechnology startups in San Francisco. In 2010, he co-founded Triventures, an early-stage medical technology fund with offices in Palo Alto and Tel Aviv. -
Caroline Fleck
Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences
BioDr. Caroline Fleck received her doctorate in Psychology & Neuroscience from Duke University, and went on to specialize in cognitive behavioral therapies including Exposure and Response Prevention, Dialectical Behavior Therapy, Parent Management Training, Gottman Method Couples Therapy, and Behavioral Activation. She is the founder and clinical director of Luma - a network of evidence-based clinicians in private practice. Dr. Fleck is also a trainer, educator, and public speaker on the topics of evidence-based approaches in psychology, mindfulness, and the use of technology in mental health care. Her lectures and courses at Stanford focus on training residents, post-docs, and faculty in Dialectical Behavior Therapy, and risk management.
More information can be found on her website: https://www.drcarolinefleck.com/ -
Dominik Fleischmann
Professor of Radiology (Cardiovascular Imaging)
Current Research and Scholarly InterestsNon-invasive Cardiovascular Imaging
Image Post-processing
Contrast Medium Dynamics -
Barry Fleisher
Associate Professor of Pediatrics at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsNeonatology, neurobehavioral development, outcomes in premature infants.
-
Lazar Fleishman
Professor of Slavic Languages and Literature
BioLazar Fleishman studied at a music school and the Music Academy in Riga, Latvia before graduating from Latvian State University in 1966. His first scholarly papers (on Pushkin, the Russian elegy, and Boris Pasternak) were published during his university years. He emigrated to Israel in 1974, where his academic career began at the Department for Russian Studies and the Department of Comparative Literature at the Hebrew University of Jerusalem. He was co-founder and co-editor of the series Slavica Hierosolymitana: Slavic Studies of Hebrew University (1977-1984). He was Visiting Professor at the University of California, Berkeley (1978-1979; 1980-1981), The University of Texas at Austin (1981-1982), Harvard, and Yale (1984-1985) before joining the Stanford faculty in 1985. He also taught at the Russian State University for the Humanities, Princeton, Latvian State University, Charles University in Prague (Czech Republic), and the University of Vienna, Austria. His research interests encompass the history of 19th and 20th century Russian literature (especially, Pushkin, Pasternak, and Russian modernism); poetics; literary theory; 20th-century Russian history; Russian émigré literature, journalism and culture. He is the founder of the series Stanford Slavic Studies (1987-present), editor of the series Studies in Russian and Slavic Literatures and History (Boston: Academic Studies Press, 2007-present) and co-editor of the series Verbal Art: Studies in Poetics (Fordham, formerly Stanford University Press).
-
Annesa Flentje
Professor (Research) of Medicine (Stanford Prevention Research Center)
BioAnnesa Flentje, PhD, is a Professor at Stanford University in the Stanford Prevention Research Center, Department of Medicine, School of Medicine. Dr. Flentje is a clinical psychologist who uses multiple methods to understand the impacts of stress and coping on human health and disease. Her research has investigated how stress directly impacts health outcomes and how these processes are mediated through both behaviors (e.g., substance use and coping) and molecular mechanisms (e.g., epigenetics and transcriptional regulation). Dr. Flentje has developed cognitive behavioral interventions to reduce stress, and identified these as a mechanism to alter immune pathways in gene expression. Dr. Flentje is currently leading a large comparative effectiveness study of two interventions for posttraumatic stress symptoms among LGBTQIA+ populations in California. Dr. Flentje has developed and led nationwide mentoring initiatives to support health research of understudied populations and translational research to improve health. Dr. Flentje is Co-Director of The PRIDE Study (pridestudy.org), a national longitudinal cohort study of LGBTQIA+ individuals within the United States that has enrolled over 30,000 participants and is approaching 10 years of data collection.
